These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 34156683

  • 21. An Iranian scoring system for diagnosing Buerger's disease.
    Ramin M, Salimi J, Meysamie A.
    Acta Med Iran; 2014 Feb 22; 52(1):60-5. PubMed ID: 24658990
    [Abstract] [Full Text] [Related]

  • 22. Platelet receptor HPA-1 polymorphism of alphaIIbbeta3 and 807 C/T polymorphism of alpha2beta1 and Buerger's disease.
    Ostojic L, Zelenika D, Zotz RB, Sucker C, Ostojic Z, Loncar R.
    Angiology; 2007 Feb 22; 58(2):169-74. PubMed ID: 17495265
    [Abstract] [Full Text] [Related]

  • 23. Evidence for an HLA-linked resistance gene in Buerger's disease.
    de Moerloose P, Jeannet M, Mirimanoff P, Bouvier CA.
    Tissue Antigens; 1979 Aug 22; 14(2):169-73. PubMed ID: 91227
    [Abstract] [Full Text] [Related]

  • 24. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
    Yaghouti N, Boostani R, Mohamamdi A, Poursina Z, Rezaee SA, Vakili V, Valizadeh N, Shams A, Rafatpanah H.
    Viral Immunol; 2019 Mar 22; 32(2):89-94. PubMed ID: 30585773
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic criteria of Buerger's disease.
    Shionoya S.
    Int J Cardiol; 1998 Oct 01; 66 Suppl 1():S243-5; discussion S247. PubMed ID: 9951826
    [Abstract] [Full Text] [Related]

  • 26. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
    Karuppagounder V, Arumugam S, Thandavarayan RA, Pitchaimani V, Sreedhar R, Afrin R, Harima M, Suzuki H, Nomoto M, Miyashita S, Suzuki K, Nakamura M, Watanabe K.
    Exp Dermatol; 2015 Jun 01; 24(6):418-23. PubMed ID: 25739980
    [Abstract] [Full Text] [Related]

  • 27. Pathology and pathogenesis of Buerger's disease.
    Tanaka K.
    Int J Cardiol; 1998 Oct 01; 66 Suppl 1():S237-42. PubMed ID: 9951825
    [Abstract] [Full Text] [Related]

  • 28. [Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].
    Xiu G, Xiong W, Yin Y, Chen X, Liu P, Sun J, Ling B.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep 01; 30(9):830-835. PubMed ID: 30309407
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR.
    J Vasc Surg; 2008 Dec 01; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [Abstract] [Full Text] [Related]

  • 30. Buerger's disease or Buerger's syndrome? An analysis of 12 cases.
    Scharf GM, van Wyk FA, Cloete GN, Rautenbach BK.
    S Afr Med J; 1986 Dec 20; 70(13):803-5. PubMed ID: 3798265
    [Abstract] [Full Text] [Related]

  • 31. The prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature.
    Fernandez B, Strootman D.
    Angiology; 2006 Dec 20; 57(1):99-102. PubMed ID: 16444463
    [Abstract] [Full Text] [Related]

  • 32. Decrease in prevalence of Buerger's disease in Japan.
    Matsushita M, Nishikimi N, Sakurai T, Nimura Y.
    Surgery; 1998 Sep 20; 124(3):498-502. PubMed ID: 9736901
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of the receptor for advanced glycation inhibits lipopolysaccharide-mediated High mobility group protein B1 and Interleukin-6 synthesis in human gingival fibroblasts through the NF-κB signaling pathway.
    Huang J, Xiong T, Zhang Z, Tan Y, Guo L.
    Arch Oral Biol; 2019 Sep 20; 105():81-87. PubMed ID: 31288145
    [Abstract] [Full Text] [Related]

  • 34. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
    Li J, Wang FP, She WM, Yang CQ, Li L, Tu CT, Wang JY, Jiang W.
    J Viral Hepat; 2014 Feb 20; 21(2):129-40. PubMed ID: 24383926
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
    Sato T, Tamai H, Kobayashi M, Yamamoto K, Komori K.
    Cardiovasc Pathol; 2011 Feb 20; 20(5):266-71. PubMed ID: 20708412
    [Abstract] [Full Text] [Related]

  • 36. Thromboangiitis obliterans: an old disease in need of a new look.
    Adar R, Papa MZ, Schneiderman J.
    Int J Cardiol; 2000 Aug 31; 75 Suppl 1():S167-70; discussion S171-3. PubMed ID: 10980358
    [Abstract] [Full Text] [Related]

  • 37. RAGE-dependent NF-kB inflammation processes in the capsule of frozen shoulders.
    Yano T, Hagiwara Y, Ando A, Kanazawa K, Koide M, Sekiguchi T, Itaya N, Onoki T, Suzuki K, Tsuchiya M, Sogi Y, Yabe Y, Itoi E.
    J Shoulder Elbow Surg; 2020 Sep 31; 29(9):1884-1891. PubMed ID: 32279986
    [Abstract] [Full Text] [Related]

  • 38. HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway.
    Xie Y, Yu N, Chen Y, Zhang K, Ma HY, Di Q.
    Mol Med Rep; 2017 Aug 31; 16(2):1691-1700. PubMed ID: 28627626
    [Abstract] [Full Text] [Related]

  • 39. Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways.
    Zou C, Liu L, Huang C, Hu S.
    Front Pharmacol; 2022 Aug 31; 13():1018438. PubMed ID: 36304158
    [Abstract] [Full Text] [Related]

  • 40. Decrease in the incidence of Buerger's disease recurrence in northern Thailand.
    Laohapensang K, Rerkasem K, Kattipattanapong V.
    Surg Today; 2005 Aug 31; 35(12):1060-5. PubMed ID: 16341487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.